The black box warning: Decreased prescriptions and increased youth suicide?

American Journal of Psychiatry

Volumn 164, Issue 12, 2007, Pages 1907-

  Jureidini, Jon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

CHILD PSYCHIATRY; DRUG USE; HEALTH PROMOTION; HUMAN; INCIDENCE; LETTER; PRESCRIPTION; PRIORITY JOURNAL; SUICIDE; UNITED STATES; ADOLESCENT; AGE; CHILD; CHILD PSYCHOLOGY; DEPRESSION; DRUG LABELING; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; LEGAL ASPECT; NOTE; PSYCHOLOGICAL ASPECT; STATISTICS;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; AGE FACTORS; CHILD; DEPRESSIVE DISORDER; DRUG LABELING; DRUG UTILIZATION; HUMANS; PRESCRIPTIONS, DRUG; SEROTONIN UPTAKE INHIBITORS; SUICIDE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 38449101732     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07091463     Document Type: Letter

References (3)

1. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings R, Mann JJ: Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007; 164:1356-1363
2. Kung HC, Hoyert DL, Xu J, Murphy SL: Deaths: Preliminary Data for 2005. Hyattsville, Md, National Center for Health Statistics, 2005. http://www.cdc.gov/nchs/products/pubs/pubd/hestats/prelimdeaths05/ prelimdeaths05.htm (accessed September 2007)
3. Leckman JF, King RA: A developmental perspective on the controversy surrounding the use of SSRIs to treat pediatric depression (editorial). Am J Psychiatry 2007; 164:1304-1306